Connection

Charles Greenberg to Transglutaminases

Back to Details
This is a "connection" page, showing publications Charles Greenberg has written about Transglutaminases.
Charles Greenberg
Connection Strength
5.970
Transglutaminases
  1. Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide. Sci Rep. 2017 11 23; 7(1):16163.
    View in: PubMed
    Score: 0.558
  2. Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes. Amino Acids. 2017 03; 49(3):501-515.
    View in: PubMed
    Score: 0.504
  3. Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation. Amino Acids. 2013 Oct; 45(4):857-64.
    View in: PubMed
    Score: 0.419
  4. TGM2 and implications for human disease: role of alternative splicing. Front Biosci (Landmark Ed). 2013 01 01; 18(2):504-19.
    View in: PubMed
    Score: 0.398
  5. Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Sci. 2010 Feb; 19(2):229-35.
    View in: PubMed
    Score: 0.325
  6. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol. 2008 Sep 22; 15(9):969-78.
    View in: PubMed
    Score: 0.296
  7. Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. FASEB J. 2007 Dec; 21(14):4131-43.
    View in: PubMed
    Score: 0.272
  8. Roles of transglutaminases in cardiac and vascular diseases. Front Biosci. 2007 Jan 01; 12:2530-45.
    View in: PubMed
    Score: 0.262
  9. Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. J Neurochem. 2004 Mar; 88(5):1253-60.
    View in: PubMed
    Score: 0.216
  10. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry. 2001 Apr 24; 40(16):4904-10.
    View in: PubMed
    Score: 0.177
  11. Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth. Lab Invest. 1999 Dec; 79(12):1679-86.
    View in: PubMed
    Score: 0.161
  12. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 1999 Oct; 13(13):1787-95.
    View in: PubMed
    Score: 0.159
  13. Site-directed mutagenesis of the calcium-binding site of blood coagulation factor XIIIa. J Biol Chem. 1999 Aug 27; 274(35):24953-8.
    View in: PubMed
    Score: 0.158
  14. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem. 1998 Jan 16; 273(3):1776-81.
    View in: PubMed
    Score: 0.141
  15. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. J Biol Chem. 1997 Oct 03; 272(40):25149-56.
    View in: PubMed
    Score: 0.138
  16. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J Biol Chem. 1997 Jun 27; 272(26):16295-300.
    View in: PubMed
    Score: 0.136
  17. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J Biol Chem. 1996 Dec 06; 271(49):31191-5.
    View in: PubMed
    Score: 0.131
  18. Tissue transglutaminase expression in human breast cancer. Lab Invest. 1996 Nov; 75(5):637-45.
    View in: PubMed
    Score: 0.130
  19. Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis. J Biol Chem. 1994 Nov 11; 269(45):28309-13.
    View in: PubMed
    Score: 0.113
  20. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites. J Biol Chem. 1993 Oct 05; 268(28):21284-92.
    View in: PubMed
    Score: 0.105
  21. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. Anal Biochem. 1992 Aug 15; 205(1):166-71.
    View in: PubMed
    Score: 0.097
  22. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991 Dec; 5(15):3071-7.
    View in: PubMed
    Score: 0.092
  23. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. J Biol Chem. 1990 Feb 25; 265(6):3543-8.
    View in: PubMed
    Score: 0.082
  24. Consequences of terbium (III) binding on the conformation and enzymatic activity of guinea pig liver transglutaminase. Mol Cell Biochem. 1989 Jan 23; 85(1):57-65.
    View in: PubMed
    Score: 0.076
  25. Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun. 1988 Nov 30; 157(1):115-20.
    View in: PubMed
    Score: 0.075
  26. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin. J Biol Chem. 1988 Oct 05; 263(28):14296-301.
    View in: PubMed
    Score: 0.074
  27. Transglutaminases: the missing link in nephrogenic systemic fibrosis. Am J Dermatopathol. 2007 Oct; 29(5):433-6.
    View in: PubMed
    Score: 0.069
  28. The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization. Blood. 1987 Sep; 70(3):702-9.
    View in: PubMed
    Score: 0.069
  29. Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling? J Vasc Res. 2007; 44(5):339-44.
    View in: PubMed
    Score: 0.067
  30. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem. 1987 Feb 05; 262(4):1901-6.
    View in: PubMed
    Score: 0.066
  31. Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity. Cancer Res. 2005 Feb 15; 65(4):1369-75.
    View in: PubMed
    Score: 0.058
  32. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res. 2002 Jan; 20(1):76-82.
    View in: PubMed
    Score: 0.046
  33. Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. Lab Invest. 2001 Jan; 81(1):83-93.
    View in: PubMed
    Score: 0.043
  34. Purification and characterization of recombinant human coagulant factor XIII A-chains expressed in E. coli. Protein Expr Purif. 1994 Apr; 5(2):125-32.
    View in: PubMed
    Score: 0.027
  35. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1991 Aug; 34(8):996-1005.
    View in: PubMed
    Score: 0.023
  36. Tb(III)-ion-binding-induced conformational changes in platelet factor XIII. Biochem J. 1989 Jan 15; 257(2):331-8.
    View in: PubMed
    Score: 0.019
  37. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. Biochim Biophys Acta. 1988 Sep 08; 966(3):328-35.
    View in: PubMed
    Score: 0.018
  38. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets. Thromb Haemost. 1988 Aug 30; 60(1):88-93.
    View in: PubMed
    Score: 0.018
  39. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. Arch Biochem Biophys. 1988 Apr; 262(1):142-8.
    View in: PubMed
    Score: 0.018
  40. The binding of divalent metal ions to platelet factor XIII modulates its proteolysis by trypsin and thrombin. Arch Biochem Biophys. 1988 Feb 15; 261(1):112-21.
    View in: PubMed
    Score: 0.018
  41. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII. Blood. 1987 Mar; 69(3):867-71.
    View in: PubMed
    Score: 0.017
  42. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Biochim Biophys Acta. 1986 Aug 15; 872(3):261-8.
    View in: PubMed
    Score: 0.016
  43. Thrombin binding to fibrin is necessary for fibrin polymers to enhance factor XIIIa formation. Semin Thromb Hemost. 1986 Jul; 12(3):226-7.
    View in: PubMed
    Score: 0.016
  44. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation. Blood. 1985 Aug; 66(2):466-9.
    View in: PubMed
    Score: 0.015
  45. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest. 1985 May; 75(5):1463-70.
    View in: PubMed
    Score: 0.015
  46. Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline. Anal Biochem. 1985 Jan; 144(1):165-71.
    View in: PubMed
    Score: 0.014
  47. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. J Biol Chem. 1984 Dec 10; 259(23):14721-7.
    View in: PubMed
    Score: 0.014
  48. SU5416 delays wound healing through inhibition of TGF-beta 1 activation. Cancer Biol Ther. 2002 Mar-Apr; 1(2):121-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.